Inhibition by cholesterylphosphorylserine of T-cell-mediated immune responses in mice

Int J Immunopharmacol. 1995 Jun;17(6):517-21. doi: 10.1016/0192-0561(95)00027-y.

Abstract

The synthetic analogue of phosphatidylserine, cholesterylphosphorylserine (CPHS) inhibits T-cell-mediated immune responses in mice. Tested in cultured mouse spleen cells, CPHS inhibits concanavalin A-induced activation of DNA synthesis (IC50, 3.5 microM). Injected i.p. during the efferent phase, CPHS (25-100 mg/kg) inhibits the manifestations of delayed-type of hypersensitivity. The compound (25 mg/kg i.p., daily) reduces the acute graft-versus-host reaction when given for 5 days to donor mice before the isolation of spleen cells used for the inoculum. These data suggest that the addition of a phosphorylserine group to a steroid ring may produce immunoregulatory compounds.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / pharmacology*
  • Animals
  • Cholesterol / analogs & derivatives*
  • Cholesterol / immunology
  • Cholesterol / pharmacology*
  • Graft vs Host Reaction / drug effects
  • Hypersensitivity, Delayed / prevention & control
  • Lymphocyte Activation / drug effects
  • Male
  • Mast Cells / drug effects
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Phosphatidylserines / immunology
  • Phosphatidylserines / pharmacology*
  • Phosphoserine / analogs & derivatives*
  • Phosphoserine / immunology
  • Phosphoserine / pharmacology
  • Spleen / cytology
  • Spleen / drug effects
  • T-Lymphocytes / drug effects*

Substances

  • Adjuvants, Immunologic
  • Phosphatidylserines
  • cholesterylphosphorylserine
  • Phosphoserine
  • Cholesterol